GE HealthCare Technologies(NASDAQ) GEHC

GE HealthCare Technologies Inc. helps doctors see inside their patients. These tools find diseases and help plan the best treatments. It also sells dyes that make medical scans much clearer.

The Diagnostic Toolkit

• Advanced Imaging Solutions: Combined segment for scanners like Computed Tomography (CT), which uses X-rays for body pictures, and Magnetic Resonance (MR), which uses magnets; generated $3.8 billion in the three months ended June 30, 2026.
• Pharmaceutical Diagnostics: Contrast media liquids and radioactive tracers that help doctors see internal tissues better during scans; earned $843 million during the second quarter of 2026.
• Patient Care Solutions: Medical devices and software for monitoring patients and delivering anesthesia or respiratory care; brought in $675 million in the three months ended June 30, 2026.

Strategic Moves and Mergers

• Combined the Imaging and Advanced Visualization Solutions businesses into a new operating segment called Advanced Imaging Solutions in the second quarter of 2026.
• Spent $2.3 billion to purchase Intelerad, a medical imaging software company, during the first half of 2026.
• Completed the acquisition of the remaining 50% interest in Nihon Medi-Physics Co., Ltd. in 2025 to expand diagnostic agent offerings.
• Invested $278 million in manufacturing capacity and new product development during the six months ended June 30, 2026.

Global Reach and Precision

The company operates an extensive international network across North America, Europe, and China to support diverse clinical needs. It integrates advanced digital software with traditional medical hardware to improve diagnostic accuracy and hospital efficiency.

The Financial Scorecard

• Total revenues grew 6.6% to $10.4 billion in the six-month period ended June 30, 2026.
• Operating income was $1.25 billion for the first half of 2026, down 2.3% year over year.
• Free cash flow hit $180 million in the six months ended June 30, 2026, up 70% year over year.
• Total debt stood at $10.1 billion as of June 30, 2026, compared to $10.0 billion at the end of 2025.
• Tariff refunds provided a $106 million pre-tax benefit in the second quarter of 2026.

Bottom Line

GE HealthCare has evolved into an independent entity focused on combining imaging hardware with digital and pharmaceutical diagnostics. Its strategy relies on international expansion and integrating software to improve diagnostic accuracy and clinical workflows.